首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1701013

流式細胞技術市場規模、佔有率、成長分析（按技術、產品、應用、最終用戶和地區）- 2025 年至 2032 年產業預測

Flow Cytometry Market Size, Share, Growth Analysis, By Technology, By Product, By Application, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年04月02日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計 2023 年全球流式細胞技術市場規模將達到 61 億美元，並從 2024 年的 66.9 億美元成長到 2032 年的 139.2 億美元，預測期內（2025-2032 年）的複合年成長率為 9.6%。

由於癌症、免疫疾病和感染疾病的發生率不斷上升，流式細胞技術市場預計將經歷顯著成長。生物技術、生命科學和生物製藥領域不斷增加的研發投入正在推動對流式細胞技術儀的需求。技術進步，例如用於照護現場檢驗（POC）的微流體流式細胞技術的出現，正在提高這些儀器的分析能力。例如，這些創新測試利用流式細胞技術提供對患者對 COVID-19 抗原的反應的關鍵見解，從而有助於做出明智的治療決策。隨著全球感染疾病疫情持續上升，流式細胞技術技術的採用預計將成長，進一步促進未來幾年的產業發展動能。

市場概覽
試劑和耗材
- 抗體
- 檢測方法和套件
- 其他試劑和耗材
裝置
- 細胞分析儀
- 高量程細胞分析儀
- 中階細胞分析儀
- 低量程細胞分析儀
- 細胞分選裝置
- 高範圍細胞分選器
- 中階細胞分選儀
- 低量程細胞分選儀
服務
軟體
配件

流式細胞技術市場規模（依應用）及複合年成長率（2025-2032）

市場概覽
研究用途
- 製藥和生物技術
- 藥物研發
- 幹細胞研究
- 管內毒性測試
- 免疫學
- 細胞分選
- 細胞凋亡
- 細胞週期分析
- 細胞活力
- 細胞計數
- 其他研究應用
臨床應用
- 癌症診斷
- 血液學
- 自體免疫疾病
- 器官移植
- 其他臨床應用
工業應用

流式細胞技術市場規模（按最終用戶和複合年成長率） (2025-2032)

市場概覽
學術研究所
醫院和臨床實驗室
製藥和生物技術公司

流式細胞技術市場規模及複合年成長率（2025-2032）

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）
  主要企業簡介
  - 碧迪公司（美國）
  - 丹納赫公司（美國）
  - 賽默飛世爾科技公司（美國）
  - 安捷倫科技公司（美國）
  - 索尼集團公司（日本）
  - Bio-Rad Laboratories, Inc.（美國）
  - Miltenyi BIoTec GmbH（德國）
  - Enzo Biochem公司（美國）
  - Sysmex株式會社（日本）
  - bioMErieux SA（法國）
  - Cytonome, LLC（美國）
  - 賽多利斯股份公司（德國）
  - Cytek Biosciences, Inc.（美國）
  - Apogee Flow Systems Ltd.（英國）
  - 默克集團（德國）
  - 貝克曼庫爾特公司（美國）
  - Stratedigm公司（美國）
  - Nanocellect Biomedical（美國）

結論和建議

簡介目錄

Product Code: SQMIG35H2031

Global Flow Cytometry Market size was valued at USD 6.1 billion in 2023 and is poised to grow from USD 6.69 billion in 2024 to USD 13.92 billion by 2032, growing at a CAGR of 9.6% during the forecast period (2025-2032).

The flow cytometry market is poised for significant growth, driven by the increasing incidence of cancer, immune disorders, and infectious diseases. Rising R&D investments in biotechnology, life sciences, and biopharmaceutical sectors are fueling the demand for flow cytometry instruments. Technological advancements, such as the emergence of microfluidic flow cytometry for Point-of-Care (POC) testing, are enhancing the analytical capabilities of these instruments. For instance, these innovative tests utilize flow cytometry to provide critical insights into patients' responses to COVID-19 antigens, facilitating informed treatment decisions. As the prevalence of infectious diseases continues to rise globally, the adoption of flow cytometry techniques is expected to expand, further contributing to industry momentum in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Flow Cytometry market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Flow Cytometry Market Segments Analysis

Global Flow Cytometry Market is segmented by Technology, Product, Application, End User and region. Based on Technology, the market is segmented into Cell-Based Flow Cytometry and Bead-Based Flow Cytometry. Based on Product, the market is segmented into Reagents & Consumables, Instruments, Services, Software and Accessories. Based on Application, the market is segmented into Research Applications, Clinical Applications and Industrial Applications. Based on End User, the market is segmented into Academic & Research Institutes, Hospitals & Clinical Testing Laboratories and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Flow Cytometry Market

The rising focus on personalized medicine and targeted therapies is significantly boosting the demand for advanced flow cytometry techniques. Flow cytometry's capability to simultaneously analyze multiple parameters enhances the precise characterization of cells, which is essential in formulating individualized treatment strategies. This technology allows for a deeper understanding of cellular properties and behaviors, making it an invaluable tool in the development of tailored therapeutic approaches. As healthcare increasingly prioritizes personalized treatment options, the role of flow cytometry in accurately assessing and monitoring patient conditions will continue to expand, thereby driving growth in the market.

Restraints in the Flow Cytometry Market

The flow cytometry market faces significant constraints due to the high initial investment and ongoing maintenance costs associated with the equipment. These financial barriers can be a deterrent for many laboratories and institutions, particularly smaller or underfunded facilities that may struggle to allocate sufficient resources for such advanced technology. As a result, the reluctance or inability to invest in flow cytometry can hinder its adoption and integration into various research and clinical settings. Consequently, this financial challenge may limit the overall growth potential of the flow cytometry market, impacting its accessibility and utilization across the healthcare and research sectors.

Market Trends of the Flow Cytometry Market

The flow cytometry market is witnessing a transformative phase, significantly influenced by advancements in cell sorting technologies that enhance the ability to isolate and analyze individual cell populations. This is particularly impactful in critical fields such as cancer research, immunology, and stem cell research, where high purity and accuracy are paramount. The increasing demand for precise cellular analysis in both research and clinical environments is propelling market growth, highlighting the pivotal role of flow cytometry in personalized medicine and targeted therapies. As researchers and clinicians seek innovative solutions to unravel complex cellular behaviors, the flow cytometry market is poised for sustained expansion and innovation.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Regulatory Analysis
Technology Analysis
Case Studies

Global Flow Cytometry Market Size by Technology & CAGR (2025-2032)

Market Overview
Cell-Based Flow Cytometry
Bead-Based Flow Cytometry

Global Flow Cytometry Market Size by Product & Service & CAGR (2025-2032)

Market Overview
Reagents & Consumables
- Antibodies
- Assays & Kits
- Other Reagents & Consumables
Instruments
- Cell Analyzers
- High-range cell analyzers
- Mid-range cell analyzers
- Low-range cell analyzers
- Cell Sorters
- High-range cell sorters
- Mid-range cell sorters
- Low-range cell sorters
Services
Software
Accessories

Global Flow Cytometry Market Size by Application & CAGR (2025-2032)

Market Overview
Research Applications
- Pharmaceutical & Biotechnology
- Drug Discovery
- Stem Cell Research
- In Vitro Toxicity Testing
- Immunology
- Cell Sorting
- Apoptosis
- Cell Cycle Analysis
- Cell Viability
- Cell Counting
- Other Research Applications
Clinical Applications
- Cancer Diagnostics
- Hematology
- Autoimmune Diseases
- Organ Transplantation
- Other Clinical Applications
Industrial Applications

Global Flow Cytometry Market Size by End User & CAGR (2025-2032)

Market Overview
Academic & Research Institutes
Hospitals & Clinical Testing Laboratories
Pharmaceutical & Biotechnology Companies

Global Flow Cytometry Market Size & CAGR (2025-2032)

North America (Technology, Product & Service, Application, End User)
- US
- Canada
Europe (Technology, Product & Service, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Product & Service, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Product & Service, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Product & Service, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Becton, Dickinson, and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sony Group Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMErieux S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytonome, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytek Biosciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Apogee Flow Systems Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stratedigm, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nanocellect Biomedical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments